|
Anastrozole, Letrozole, Nolatrexed 2Hcl, Palonosetron Hcl, Azasetron Hcl, Ibandronate Sodium, Zoledronic Acid, Docetaxel Trihydrate,
Cytarabine Hcl,
Rubitecan, Bicalutamide, Lonidamine, Irsogladine Maleate, Levosimendan, Tamoxifen,
Ziprasidone Hcl, Adefovir, Fludarabine Phosphate, Gemcitabine Hcl, Melphalan, Roxatidine Acetate Hcl, Temozolomide, Voriconazole, Ezetimibe, Irinotecan Hcl, Topotecan Hcl, Paclitaxel, Cladribine, Amifostine, Fluvoxamine Maleate.
|
|
|
|
|
|
|
| Posted by |
xiong l.x
|
| e-Mail //echo Email ?> | Contact company |
Company
| Fei Da
| | Address | C9-2-602,Dongxinyuan, | City & ZIP
| Hangzhou, 310004
| Country
| China
| Phone
| For registered Members only.
| Fax
| For registered Members only.
| | Key Customers / Clientele | Pharmaceutical Raw Materials | | Company Profile | Anastrozole,Letrozole,Azasetron Hcl,Ibandronate Sodium,Zoledronic Acid,
Docetaxel,Cytarabine Hcl... | | URL | For registered Members only. | | Rating | (0 reviews) | | Popular tags | | |
| |
|
 | | Keywords (seperated by comma) | pharmaceutical raw materials | | Product Specifications | Anastrozole,
Letrozole,
Nolatrexed 2Hcl,
Palonosetron Hcl,
Azasetron Hcl,
Ibandronate Sodium,
Zoledronic Acid,
Docetaxel Trihydrate,
Cytarabine Hcl,
Rubitecan,
Bicalutamide,
Lonidamine,
Irsogladine Maleate,
Levosimendan,
Tamoxifen,
Zi | | Industry Category | Pharmaceutical Raw Materials | | Quality/Safety Certifications | | | Delivery Lead Time | 7 days | | Payment & Price Terms | T/T advance | | My Offers | Anastrozole,
Letrozole,
Nolatrexed 2Hcl,
Palonosetron Hcl,
Azasetron Hcl,
Ibandronate Sodium,
Zoledronic Acid,
Docetaxel Trihydrate,
Cytarabine Hcl,
Rubitecan,
Bicalutamide,
Lonidamine,
Irsogladine Maleate,
Levosimendan,
Tamoxifen,
Zi | | Product Portfolio / Other Products | | | Customers | worldwide | | Detailed Company Introduction | | | FOB Price & Port | | | Packaging Details | | | Our Team | | | Web Site | For registered Members only. |
|
|
|
|
|
| Product Details |
| Product id |
11451 |
| Visits |
1020 |
| Date |
2006.03.10 |
|
|
|  |
|
| |
|
|
|